MedPath

Taiwan Biotech Co., Ltd.

Taiwan Biotech Co., Ltd. logo
🇹🇼Taiwan
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

25

PHILIPPINES:25

Drug Approvals

Forazole-IV

Approval Date
Jul 14, 2025
PHILIPPINES

Amizol

Approval Date
Jul 14, 2025
PHILIPPINES

Patryl

Approval Date
Jul 14, 2025
PHILIPPINES

PHARMINE

Approval Date
Jul 14, 2025
PHILIPPINES

Aminomyn

Approval Date
Jul 14, 2025
PHILIPPINES

Aminogen-S

Approval Date
Jul 14, 2025
PHILIPPINES

Naprilate

Approval Date
Jul 14, 2025
PHILIPPINES

Drinex

Approval Date
Jul 14, 2025
PHILIPPINES

Zefrax

Approval Date
Jul 14, 2025
PHILIPPINES

Suremine

Approval Date
Jul 14, 2025
PHILIPPINES
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

Optimizing the Treatment of Toenail Onychomycosis Using a New Transdermal Patch Combined With Terbinafine/Ketoconazole

Phase 1
Conditions
Onychomycosis
Interventions
Drug: 3 mg terbinafine and 2 mg ketoconazole containing patch
Drug: 6 mg terbinafine and 2 mg ketoconazole containing patch
Drug: 8 mg terbinafine and 2 mg ketoconazole containing patch
First Posted Date
2012-06-11
Last Posted Date
2012-06-11
Lead Sponsor
Taiwan Biotech Co., Ltd.
Target Recruit Count
18
Registration Number
NCT01615913
Locations
🇨🇳

Taipei Medical University Hospital, Taipei, Taiwan

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.